Cost is roughly comparable across formats
They are not intended for human or animal consumption, diagnosis, treatment, cure, or prevention of any disease.
Though data is still emerging, it appears that GLP-1 RAs show promise as a potential adjunct medication for IIH patients with benefits that extend beyond weight loss
If your clinician finds thyroid dysfunction, insulin resistance, or chronic inflammation driving your weight gain, we address those alongside GLP-1 therapy
Retatrutide is a weekly injection that acts on three hormone receptors to support weight loss
GLP-1s are incretin-based agents that amplify glucose-stimulated insulin secretion, suppress inappropriate glucagon release, slow gastric emptying, and promote satiety